Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzelnick

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
Trends in Microbiology|January 29, 2014
Global spread of dengue virus types: mapping the 70 year historyJane P Messina, Oliver J Brady, Thomas W Scott, et al.
Nature Communications|February 18, 2021
A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humansUsha K Nivarthi, Jesica Swanstrom, Matthew J Delacruz, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Immunity to non-dengue flaviviruses impacts dengue virus IgG ELISA specificity in CambodiaCamila Odio, Christina Yek, Chloe M Hasund, et al.
Nature Communications|December 18, 2019
Impacts of Zika emergence in Latin America on endemic dengue transmissionRebecca K Borchering, Angkana T Huang, Luis Mier-Y-Teran-Romero, et al.
General Hospital Psychiatry|July 21, 2018
Initial outcomes of a real-world multi-site primary care psychotherapy programCraig N Sawchuk, Julia R Craner, Summer L Berg, et al.
The Lancet. Infectious Diseases|December 25, 2019
Age-dependent manifestations and case definitions of paediatric Zika: a prospective cohort studyRaquel Burger-Calderon, Fausto Bustos Carrillo, Lionel Gresh, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
The association of neutralizing antibodies with protection against symptomatic dengue virus infection varies by serotype, prior infection history, and assay conditionSandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, et al.
Plos Neglected Tropical Diseases|October 26, 2018
Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virusLeah C Katzelnick, Ana Coello Escoto, Benjamin D McElvany, et al.
Nature Communications|January 9, 2024
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotypeSandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, et al.
Focus (American Psychiatric Publishing)|February 5, 2020
Impact of A National Collaborative Care Initiative for Patients With Depression and Diabetes or Cardiovascular DiseaseRebecca C Rossom, Leif I Solberg, Sanne Magnan, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Trends in Microbiology|January 29, 2014
Global spread of dengue virus types: mapping the 70 year historyJane P Messina, Oliver J Brady, Thomas W Scott, et al.
Nature Communications|February 18, 2021
A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humansUsha K Nivarthi, Jesica Swanstrom, Matthew J Delacruz, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Immunity to non-dengue flaviviruses impacts dengue virus IgG ELISA specificity in CambodiaCamila Odio, Christina Yek, Chloe M Hasund, et al.
Nature Communications|December 18, 2019
Impacts of Zika emergence in Latin America on endemic dengue transmissionRebecca K Borchering, Angkana T Huang, Luis Mier-Y-Teran-Romero, et al.
General Hospital Psychiatry|July 21, 2018
Initial outcomes of a real-world multi-site primary care psychotherapy programCraig N Sawchuk, Julia R Craner, Summer L Berg, et al.
The Lancet. Infectious Diseases|December 25, 2019
Age-dependent manifestations and case definitions of paediatric Zika: a prospective cohort studyRaquel Burger-Calderon, Fausto Bustos Carrillo, Lionel Gresh, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
The association of neutralizing antibodies with protection against symptomatic dengue virus infection varies by serotype, prior infection history, and assay conditionSandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, et al.
Plos Neglected Tropical Diseases|October 26, 2018
Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virusLeah C Katzelnick, Ana Coello Escoto, Benjamin D McElvany, et al.
Nature Communications|January 9, 2024
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotypeSandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, et al.
Focus (American Psychiatric Publishing)|February 5, 2020
Impact of A National Collaborative Care Initiative for Patients With Depression and Diabetes or Cardiovascular DiseaseRebecca C Rossom, Leif I Solberg, Sanne Magnan, et al.
Pageof 15